DROPSEPT ® -

DROPSEPT®


PATENTED OPHTHALMIC SOLUTION WITH PHLOGOLITHIC ACTION

DROPSEPT IS INDICATED FOR THE PROTECTION AND REPAIR OF THE CORNEAL AND CONJUNCTIVAL EPITHELIUM.

 

edit button text.
DROPSEPT ® -

DROPsept®


PROTECT AND REPAIR

DROPsept® is an ophthalmic solution with phlogolithic action, which protects and repairs corneal and conjunctival epithelium. It is indicated for adults and children in the treatment of symptoms such as burning, itching, photophobia, foreign body sensation and redness of the eye. DROP sept is also indicated in the treatment of ongoing inflammatory states of the ocular surface, such as conjunctivitis, keratitis, blepharitis, dacryocystitis, meibomitis, discomfort, and dry eye syndrome.

DROPsept® can be used with wearable contact lenses.

DOWNLOAD BROCHURE

INDICATIONS

DROPsept ® is indicated as an adjuvant:

  • In pre-surgical prophylaxis;
  • In the treatment of conjunctival infections;
  • In the treatment of corneal infections;
  • In the treatment of infections of the ocular annexes (eyelid margins, tear ducts, eyelashes);
  • In the treatment of conjunctivitis;
  • In the treatment of keratitis;
  • In the treatment of dacryocystitis.

BIBLIOGRAPHY

  1. Caruso C, Porta A, Tosco A, Eletto D, Pacente L, Bartollino S, Costagliola C "A Novel Vitamin E TPGS-Based Formulation Enhances Chlorhexidine Bioavailability in Corneal Layers" Pharmaceutics 2020, 12, 642 [PDF]

MANUFACTURED BY:
Iromed group S.r.l.

Via Tempio del Cielo, 3/5
00144 Rome (ITALY)
Phone: +39 06 92595490
Fax: +39 06 89360010
Email: [email protected]